Suven Life Sciences Limited
Related Stocks
About
Suven Life Sciences Limited, a clinical-stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel therapeutics for the treatment of neurodegenerative disorders in India, the United States, Europe, and internationally. The company engages in drug discovery and development of new chemical entities in central nervous system diseases. Its product candidates include Masupirdine (SUVN-502) for the treatment of Alzheimer disease and neuropsychiatric symptoms; Samelisant (SUVN-G3031), a histamine 3 receptor inverse agonist for treating sleep and cognitive disorders; and Ropanicant (SUVN-911), an Alpha4Beta2 nAChRs receptor antagonist for the treatment of depressive disorders. The company is also developing Usmarapride (SUVN-D4010), a bio-available and brain penetrant 5-HT4 receptor partial agonist for the treatment of cognitive disorders; SUVN-I6107 for treating cognitive disorders; SUVN-M8036 for the treatment of psychiatric disorders; and SUVN-D1044 for treating gastrointestinal disorders. The company was formerly known as Suven Pharmaceuticals Pvt. Ltd. and changed its name to Suven Life Sciences Limited in 2003. The company was incorporated in 1989 and is based in Hyderabad, India. Suven Life Sciences Limited operates as a subsidiary of Jasti Property and Equity Holdings Private Limited.
Price Range
52 Week
Low
124.11
High
371.00
Intraday
Low
321.15
High
336.05
Company's profit divided by outstanding shares.
Ratio of share price to its earnings per share.
Total number of outstanding shares.
Gap between today's open and yesterday's close.
Average daily traded volume.
Highest price reached in the last 30 days.
Lowest price reached in the last 30 days.
Highest price reached in the last six months.
Lowest price reached in the last six months.
Highest price reached in the last year.
Lowest price reached in the last year.
Peer Comparison
| # | Name | Price | Chg % | P/E | EPS | Mkt Cap (Cr) | 52W High | 52W Low |
|---|---|---|---|---|---|---|---|---|
| 1 | Suven Life Sciences Limited | 329.00 | -1.32% | 0.00 | -14.77 | 9,271 | 371.00 | 124.11 |
| 2 | Aarti Drugs Limited | 412.40 | +0.66% | 19.70 | 20.93 | 3,774 | 534.55 | 318.95 |
| 3 | Aarti Pharmalabs Limited | 877.90 | +1.75% | 37.32 | 23.50 | 7,986 | 946.10 | 585.00 |
| 4 | Abbott India Limited | 26,520.00 | -1.41% | 34.91 | 759.88 | 56,318 | 33,495.00 | 25,150.00 |
| 5 | ANLON HEALTHCARE LIMITED | 14.49 | +0.21% | 21.27 | 0.68 | 769 | 17.27 | 9.08 |
| 6 | Ajanta Pharma Limited | 3,724.80 | +0.05% | 41.01 | 90.83 | 46,500 | 3,796.00 | 2,329.90 |
| 7 | AKUMS DRUGS AND PHARMA L | 750.35 | +0.90% | 39.40 | 19.05 | 11,513 | 775.00 | 409.30 |
| 8 | Alivus Life Sciences Limited | 1,383.10 | -0.50% | 28.26 | 49.03 | 16,838 | 1,418.00 | 819.00 |
| 9 | Alkem Laboratories Limited | 5,471.50 | +1.80% | 30.32 | 180.45 | 65,372 | 5,933.50 | 5,075.00 |
| 10 | Amrutanjan Health Care Limited | 496.35 | +1.58% | 26.76 | 18.67 | 1,443 | 790.95 | 482.80 |
| 11 | Alembic Pharmaceuticals Limited | 831.25 | +1.02% | 23.53 | 35.27 | 16,326 | 1,002.00 | 635.80 |
| 12 | AstraZeneca Pharma India Limited | 7,678.50 | +0.38% | 112.95 | 67.85 | 19,175 | 9,849.50 | 7,551.50 |
| 13 | Aurobindo Pharma Limited | 1,637.80 | +0.63% | 25.58 | 64.00 | 95,139 | 1,682.40 | 1,016.10 |
| Median: 13 Co. | 877.90 | 0.63% | 28.26 | 35.27 | 16,326 | 1,002.00 | 635.80 |